<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00866411</url>
  </required_header>
  <id_info>
    <org_study_id>C.2007.147</org_study_id>
    <nct_id>NCT00866411</nct_id>
  </id_info>
  <brief_title>Cranial Electrotherapy Stimulation (CES) for Soldiers With Combat-Related Symptoms</brief_title>
  <acronym>CES</acronym>
  <official_title>Outcomes of Cranial Electrotherapy Stimulation (CES) With Soldiers for Combat-Related Symptoms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brooke Army Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Brooke Army Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this double-blind randomized control research study is to determine if CES
      given in a group setting for soldiers experiencing irritability is effective to reduce the
      symptom of irritability.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2007</start_date>
  <completion_date type="Anticipated">January 2010</completion_date>
  <primary_completion_date type="Anticipated">May 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Irritability Visual Analog Scale</measure>
    <time_frame>Baseline, daily x 3 weeks, 4 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>State Anxiety Scale</measure>
    <time_frame>Baseline, 3 weeks, 4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pittsburgh Sleep Quality Index</measure>
    <time_frame>Baseline, 3 weeks, 4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Epworth Sleepiness Scale</measure>
    <time_frame>Baseline, 3 weeks, 4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>General Sleep Disturbance Scale</measure>
    <time_frame>Baseline, 3 weeks, 4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep Self Care Questionnaire</measure>
    <time_frame>Baseline, 3 weeks, 4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Combat Exposure Scale</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Trauma Imagery Scale</measure>
    <time_frame>Baseline, 3 weeks, 4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>State - Anxiety Scale</measure>
    <time_frame>Baseline, 3 weeks, 4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Profile of Mood States</measure>
    <time_frame>Baseline, 3 weeks, 4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analog</measure>
    <time_frame>Daily x 3 weeks, 4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Center for Epidemiological Center for Epidemiological Studies - Depression Scale</measure>
    <time_frame>Baseline, 3 weeks, 4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression Visual Analog</measure>
    <time_frame>Daily x 3 weeks, 4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PTSD CheckList - Military Version</measure>
    <time_frame>Baseline, 3 weeks, 4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Veteran's Outcomes Survey Short Form - 36</measure>
    <time_frame>Baseline, 3 weeks, 4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medication Use Questionnaire</measure>
    <time_frame>Baseline, 3 weeks, 4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spielberger State-Trait Anger Expression Inventory-2(STAXI-2)</measure>
    <time_frame>baseline, 3 weeks, 4 weeks</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Combat Related Symptoms</condition>
  <condition>Irritability</condition>
  <condition>Anger</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>cranial electrotherapy stimulation (CES) with Alpha-Stim</intervention_name>
    <description>three weeks of the cranial electrotherapy stimulation (CES) treatment (15 sessions of 60 minute treatments)</description>
    <other_name>cranial electrotherapy stimulation</other_name>
    <other_name>CES</other_name>
    <other_name>Alpha-Stim</other_name>
    <other_name>bioelectric medicine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>three weeks of placebo treatment via a double-blinded procedure so that neither the Soldier nor the study investigators will know whether the Soldier is receiving the actual treatment or placebo</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Soldiers over 18 years old or emancipated minors willing to sign an informed consent
             and complete all protocol requirements.

          -  Soldiers who score 4 or greater on the visual analog scale for irritability

        Exclusion Criteria:

          -  Seizure disorders.

          -  Pregnancy. All female Soldiers will verify in the informed consent that they are not
             currently pregnant. Safety of stimulation has not been established during pregnancy
             and therefore we will exclude women who are or want to become pregnant during the
             course of the study.

          -  Concomitant therapy with an investigational drug or device, or participation in an
             investigational drug or device study within one month prior to entering this study

          -  Patients with a pacemaker or implanted defibrillator. The Alpha-Stim 100 may effect
             the operation of cardiac pacemakers (particularly demand type pacemakers) and
             therefore this population will be excluded from this study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mona O Bingham, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brooke Army Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Carl R. Darnall Army Medical Center</name>
      <address>
        <city>Fort Hood</city>
        <state>Texas</state>
        <zip>76544</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sharon Reese, AN, DrPH</last_name>
      <phone>254-288-8577</phone>
      <email>sharon.reese@amedd.army.mil</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Brooke Army Medical Center</name>
      <address>
        <city>Fort Sam Houston</city>
        <state>Texas</state>
        <zip>78234</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mona O Bingham, PhD</last_name>
      <phone>210-916-7159</phone>
      <email>mona.bingham@amedd.army.mil</email>
    </contact>
    <contact_backup>
      <last_name>Stacey Young-McCaughan, PhD</last_name>
      <phone>(210) 567-1942</phone>
      <email>stacey.young-mccaughan@us.army.mil</email>
    </contact_backup>
    <investigator>
      <last_name>Mona O Bingham, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 19, 2009</study_first_submitted>
  <study_first_submitted_qc>March 19, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 20, 2009</study_first_posted>
  <last_update_submitted>March 19, 2009</last_update_submitted>
  <last_update_submitted_qc>March 19, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 20, 2009</last_update_posted>
  <responsible_party>
    <name_title>LTC Mona O. Bingham, PhD, RN; Chief Nursing Reseach</name_title>
    <organization>Brooke Army Medical Center</organization>
  </responsible_party>
  <keyword>cranial electrotherapy stimulation</keyword>
  <keyword>anxiety</keyword>
  <keyword>depression</keyword>
  <keyword>pain</keyword>
  <keyword>sleep disturbance</keyword>
  <keyword>combat exposure</keyword>
  <keyword>post traumatic stress</keyword>
  <keyword>health status</keyword>
  <keyword>medication use</keyword>
  <keyword>soldiers</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

